Class Action Article

  • File A Talcum Powder Lawsuit: Talcum Powder Ovarian Cancer Lawsuits Talcum Powder Fallopian Tube Cancer Lawsuits Baby  Powder Ovarian Cancer Lawsuits Filed If you or a loved one used talcum powder products and were diagnosed with ovarian cancer, or fallopian tube can...

Class Action News

Drug Class Actions

  • Taxotere Lawyers for Permanent Hair Loss: Taxotere Baldness Lawyers For  Permanent Hair Loss Lawsuits Have you received Taxotere for breast cancer? Taxotere can result in hair loss or baldness  that is permanent. Taxotere  is a chemotherapy drug used for the treatment of breas...

Medical Device Lawsuits

  • Zimmer Hip Replacement Lawyers: Network Zimmer Hip Replacement  Lawyer Win $2 Million Against Zimmer Hip Replacement Do You Have A Faulty Zimmer M/L Taper Hip Prothesis With Connective Technology and Cobalt Chromium Head? Do You Have Have Metallosis or Chromium Cobalt T...

Posts Tagged ‘DePuy attorney’

Trials for failed DePuy Hip Replacements Ready to Begin, DePuy lawyers Accepting Cases Now

Written by Class Action Lawyer on . Posted in Arizona Multidistrict Litigation Lawyers, California Multidistrict Litigation Lawyers, Colorado Multidistrict Litigation Lawyers, Connecticut Multidistrict Litigation Lawyers, Florida Multidistrict Litigation Lawyers, Georgia Multidistrict Litigation Lawyers, Indiana Multidistrict Litigation Lawyers, Iowa Multidistrict Litigation Lawyers, Kansas Multidistrict Litigation Lawyers, Maryland Multidistrict Litigation Lawyers, Massachusetts Multidistrict Litigation Lawyers, Michigan Multidistrict Litigation Lawyers, Nevada Multidistrict Litigation Lawyers, New Jersey Multidistrict Litigation Lawyers, New Mexico Multidistrict Litigation Lawyers, New York Multidistrict Litigation Lawyers, North Carolina Multidistrict Litigation Lawyers

DePuy Hip Recall trials ready to begin. DePuy Hip Replacement Lawyers accepting cases in many states. If , need revision surgery or have had revision surgery or metal on  metal toxicity we want to speak to you right away. Only claim in state with 2 year statutes or greater are being accepted. Call right away as time is running out. If you have complications from your dePuy hip replacement see a doctor immediately
The first bellwether trials in the pending DePuy hip litigation are scheduled to begin later this year. The handful of plaintiffs involved in the trials represent just a few of the thousands of individuals who filed suit against Johnson & Johnson and DePuy Orthopedics after being injured by a defective metal hip implant. mny of these have been seniors needing revision surgeries.

According to a Bloomberg report, the first bellwether case is scheduled to go to trial in a Nevada court in December of this year. Additional bellwether trials are expected to begin in January 2013. According to the report, these cases are part of an estimated 2,000 DePuy hip lawsuits filed in state courts across the country. Several thousand more lawsuits are also pending in federal court after being consolidated into a multidistrict litigation (MDL) for pretrial proceedings. The plaintiffs involved in the DePuy hip litigation allege that they experienced pain, swelling, tissue damage, loss of mobility and other complications after being fitted with an ASR all-metal hip implant.  The lawsuits also allege that DePuy and Johnson & Johnson knew of potential problems with the metal hip replacement devices but did not take adequate steps to warn consumers of the dangers.

DePuy Orthopaedics issued a global recall of the ASR Hip Resurfacing System and ASR Acetabular System in August 2010, after data from the National Joint Registry of England and Wales showed that 1 out of every 8 patients (12%-13%) who had received the devices had to undergo revision surgery within five years of receiving it. According to Parker Waichman LLP, more than 93,000 metal-on-metal DePuy ASR hip implants were sold worldwide prior to their recall.

The U.S. Food & Drug Administration (FDA) is currently conducting a safety review of metal-on-metal hip implants, including the DePuy ASR devices. Last May, the agency directed 21 companies that market all-metal hip replacements, including DePuy, to conduct post-market studies of their products to determine if they were shedding dangerous amounts of metallic debris in patients. The FDA recently announced that its Orthopaedic and Rehabilitation Devices Panel will meet on June 27 and 28 to discuss the risks and benefits of metal-on-metal hip systems, and make potential patient and practitioner recommendations for their use.

It is strongly urged that anyone who has a failed DePuy see their Doctor immediately to find out if revision surgery is recommended and speak to a DePuy Lawyer right away



Bill Would Require More Monitering of Implants

Written by Class Action Lawyer on . Posted in Product Recall News

Bill Would Require More Monitoring of Implants
Published: December 14, 2011


Amid growing problems with artificial hips and other medical implants, bipartisan legislation was introduced in the Senate on Wednesday that would force manufacturers to track the performance of such products after they were approved for sale.

The bill would allow the Food and Drug Administration to compel companies to track implants, such as replacement hips, that belong to a category of products that do not require human testing for approval.

The proposal is an effort to address longstanding complaints by patient advocates and others like the Institute of Medicine about a system known as the 510(k) process that the F.D.A. uses to clear the sale of certain implants like artificial joints. To sell a new product under that system, a producer need only show that it is “substantially similar” to a product already on the market.

Thousands of the all-metal hips that are now failing prematurely in patients were approved through the 510(k) system. The new proposal would not require added premarket testing of such implants but would broaden the F.D.A’s postapproval oversight by giving it the authority to mandate that companies collect data on device performance. The bill, if adopted, would also tighten federal scrutiny of product recalls.

The bill was sponsored by two Democrats, Herb Kohl of Wisconsin and Richard Blumenthal of Connecticut, and a Republican, Charles E. Grassley of Iowa. In a telephone interview, Mr. Blumenthal said that the legislation would enhance patient safety without slowing device approval. He called the all-metal hips a “classic example” of why such monitoring was needed.

“There is clearly a need for scrutiny once products are implanted or used on patients,” he said.

A wave of recently introduced bills backed by the medical device industry would “streamline” F.D.A. rules to allow new products to reach market more quickly. And while the bill introduced Wednesday most likely faces an uphill fight, it may serve as a negotiating chip in a Congressional debate next year over F.D.A. device regulation.

A spokeswoman for the F.D.A., Karen Riley, said that the Obama administration had not taken a position on the bill. Wanda Moebius, a spokeswoman for a device industry trade group, the Advanced Medical Technology Association, said the group had not seen the bill but added that studies had shown that the current 510(k) approval process was “remarkably safe.”

Along with introducing the bill, the three senators sent letters Wednesday to five major producers of medical devices seeking documents about how they track product safety and recall devices.

The companies were Johnson & Johnson, an artificial joint maker; Zimmer Holdings, another producer of artificial joints; Medtronic, a heart and spinal implant producer; Boston Scientific, a heart device maker, and C. R. Bard, a surgical implant maker.

Specifically, in the case of Johnson & Johnson, Congressional investigators want to know when the company was warned that one of its all-metal hips — the A.S.R., or Articular Surface Replacement — was failing and how it tracked those problems. Last year the DePuy division of Johnson & Johnson recalled the device after it had been implanted in some 93,000 patients worldwide, including 40,000 in this country.

As of early October, about 3,500 lawsuits have been filed against Johnson & Johnson in connection with the A.S.R., and studies here and abroad suggest that the A.S.R. may have already failed a few years after implant in more than twice that number of patients here. Artificial hips are supposed to last 15 years or more before requiring replacement.

Last month, a legislative panel in Australia issued a report that concluded that Johnson & Johnson was probably aware of serious problems with the A.S.R well before recalling it. The panel also characterized the company’s responses to its questions as “decidedly opaque.”

“Many people could have avoided considerable pain, suffering and diminished quality of life if the company had acted in a responsible manner to known problems with these devices,” the Australian report stated.

In a statement, a spokeswoman for DePuy, Mindy Tinsley, said, “We believe we made the appropriate decision to recall at the appropriate time given the available information.”

Depuy Hip Replacement in the News

Written by Class Action Lawyer on . Posted in Class MDL Class Action News

Alabama couple files DePuy lawsuit over hip replacement problems
December 6th, 2011

An Alabama couple has filed a lawsuit against the makers of the DePuy ASR hip replacement. In their DePuy lawsuit, Charles and Michelle Tucker allege DePuy Orthopedics and its parent company Johnson & Johnson sold defective hip devices.

Charles Tucker received a DePuy hip implant in January 2007 and later developed pain and complications related to the device, which was recalled in July 2010. According to the lawsuit, the metal device wore down prematurely, causing damage to the surrounding bone and tissue.

DePuy has been facing mounting lawsuits concerning the ASR hip replacements after it was discovered the devices fail at a much-higher-than expected rate. According to a DePuy warning issued by the Food and Drug Administration, one in eight patients with the device will need revision surgery to correct problems within five years, a failure rate nearly three times the accepted standard.

Police In India Investigate Hip Replacement Recall

by Brian Devine on December 7, 2011

The FDA in India has registered a complaint with the Mumbai Police department regarding the DePuy hip replacement recall.

The Indian FDA and Mumbai Police have asked people in India to come forward if they have undergone a hip replacement surgery with the ASR implant.  Ramrao Desai, senior inspector, Mahim police station, said, “The FDA lodged a complaint with us 15 days back. Under IPC 328, and Drugs and Cosmetics Act 17, 18 and 27, we have registered a case against the company’s director. We request people who have an ASR hip implant to contact us.”

The Indian FDA has claimed that it doesn’t even have any data on how many patients received the implant in India.  “The police are investigating. Once the implant recipients come forward, we will know how many are affected, and accordingly take action against the company,” said an FDA official.

DePuy Hip Replacement Prompts Lawsuit in UK
December 23, 2011, 05:00:00AM. By Charles Benson 

    Merseyside, England: More than 100 people are suing a medical device company over the side effects of allegedly faulty DePuy hip replacement implants that were withdrawn a year ago, according to the BBC.

    DePuy Hip Replacement Prompts Lawsuit in UKThe news source reported that patients complained about pain and swelling, nerve, muscle and bone damage, and blood poisoning, according to a statement from their attorneys.

    The implant manufacturers DePuy have denied any liability in the case after voluntarily recalling the products in August 2010, but noted that it was not over safety concerns.

    According to the BBC, the company's ASR implant, released in 2003, used a metal cup and socket instead of a ceramic or plastic cup to replace a hip joint. This type of fixture led to reports from patients over problems with the cup and socket becoming loose.

    Stephen Ellis, 57, a Liverpool resident who had a hip replacement in 2005, fears the loosening may have led to the poisoning of his bone and muscle.

    "I woke up one morning and I was in agony. And, I felt sick, really sick with the pain," Ellis told the news source. "I feel like an old man—that's what I feel like—an old man in his eighties. And I feel robbed of my life."

    A number of other individuals in England have reported similar problems with the devices, and specific cases have targeted other side effects. One of the lead lawyers for the group of more than 100 people involved in the lawsuit noted that psychological side effects have also been present.

    "It's had a terrible effect on my clients psychologically. It's broken up relationships," the lawyer told the news source. "And they've been told that they can't find any clinical reason for the problem, initially, and that the pain was in their head."

    The problematic hip replacements have also been a target of legal action in the US, including a lawsuit by a Gaylesville, Alabama couple that was filed to seek damages stemming from the implants, according to the Rome News-Tribune.

Popular Hip Replacement Made Patients Sick
December 8, 2011 8:55 PM

The ASR hip replacement from DePuy Orthopedics was recalled after it made many patients sick. (Credit: CBS)


CHICAGO (CBS) – They trusted that the hip replacement device approved by the Food and Drug Administration was safe and would help them. Instead it made the already painful condition for some patients worse.

And as CBS 2’s Pam Zekman reports, after it was voluntarily recalled, serious and painful health problems still plague patients even after the device is removed.

“I had a job and a career that I loved,” Mary Ann Doornbos, 53 said. “I went around the world doing things.” But she also had osteoarthritis and needed hip replacement surgery in 2007.

Class Action Lawyer Network Depuy Hip Replacement Lawyers are accepting cases for the failed Depuy Hip Replacement


Depuy Issues Warning in Hip Implant Device

Written by Class Action Lawyer on . Posted in Medical Device Lawsuits

DePuy Issues Warning on Hip Implant Device

DePuy Orthopaedics, a unit of Johnson & Johnson, warned last week that its ASR artificial hip implant appears to have a high early failure rate in some patients. This warning came months after DePuy announce it was phasing out the ASR for declining sales.

According to a report in The New York Times, the warning from DePuy followed more than two years of reports that the device was failing in patients only a few years after implant causing DePuy hip replacement complications and requiring costly and painful replacement operations.

DePuy sells the ASR for use in hip “resurfacing,” a popular alternative to traditional replacement. The company also separately markets an ASR component — its hip socket, or cup — for use in traditional hip replacement. According to the Times, the Food and Drug Administration (FDA) has not approved the ASR for sale in the United States. In 2005, however, the FDA cleared the ASR cup for use in traditional hip replacement. The device was cleared through a process that did not require it to undergo clinical trials.

In a letter dated March 6, 2010 DePuy warned doctors that recently analyzed data from Australia suggested that the ASR had a higher-than-expected failure rate when used in traditional hip replacement on certain types of patient. According to the letter, patients of small stature, a group that typically includes women and patients with weak bones, faced the highest risk.

The Times is reporting that since the beginning of 2008, the FDA has received about 300 complaints against DePuy on the ASR involving patients in the U.S who received it, the Times said. Most of those patients underwent an operation to have the device replaced soon after getting it.

An official with DePuy told the Times some problems with the ASR had arisen because doctors were improperly implanting the device’s cup when first using it. But some doctors believe the ASR – which has a shallower cup than similar devices – has a design flaw, something DePuy denies. However, the co-developer of the ASR told the New York Times that he and DePuy officials realized within the last two years that the ASR cup might be more of a challenge to implant properly than competing cups.

According to The New York Times, in early 2009, DePuy sent a brochure to doctors on the importance of proper cup positioning for all hip implants. But the information did not address any specific concerns about the ASR. In its March 6 letter, DePuy emphasized the need to properly position the ASR.